ProfileJobs (804)

Celgene

Suggest Edit
    • Healthcarebiotechdrug developmenthealthtechlife sciencesoncologypharmatherapy
    Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.
    Revenue(FY, 2018)
    $15.3 B

    Employee Rating

    3.8More
    TypeSubsidiary
    Parent CompanyBristol-Myers Squibb
    HQSummit, US
    Founded1986
    Websitecelgene.com
    Celgene was founded in 1986 and is headquartered in Summit, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Celgene

    Mark J. Alles

    Mark J. Alles

    Chairman and Chief Executive Officer
    Peter N. Kellogg

    Peter N. Kellogg

    Executive Vice President and Chief Financial Officer
    Nadim Ahmed

    Nadim Ahmed

    President, Hematology & Oncology
    Terrie Curran

    Terrie Curran

    President, Inflammation and Immunology
    Rupert Vessey

    Rupert Vessey

    Executive Vice President and President, Research and Early Development
    Jonathan Biller

    Jonathan Biller

    Executive Vice President and General Counsel
    Show more

    Celgene Office Locations

    Celgene has offices in Summit, Boudry and Singapore
    Summit, US (HQ)
    86 Morris Ave
    Singapore, SG
    200 Newton Road #04-01, Newton 200
    Boudry, CH
    Route de Perreux 1
    Show all (3)
    Report incorrect company information

    Celgene Financials and Metrics

    Summary Metrics

    Founding Date

    		1986
    Celgene is a subsidiary of Bristol-Myers Squibb

    Celgene Revenue

    Embed Graph
    View revenue for all periods
    Celgene's revenue was reported to be $15.28 b in FY, 2018
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Revenue

    		6.5b7.7b9.3b11.2b13.0b15.3b

    Revenue growth, %

    		18%21%21%

    Cost of goods sold

    		340.4m385.9m420.1m438.0m461.0m587.0m

    Gross profit

    		6.2b7.3b8.8b10.8b12.5b14.7b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Revenue

    		2.3b2.8b3.0b3.3b3.3b3.5b3.8b3.9b

    Cost of goods sold

    		109.9m110.9m113.0m111.0m118.0m135.0m126.0m157.0m

    Gross profit

    		2.2b2.6b2.8b3.2b3.2b3.4b3.7b3.7b

    Gross profit Margin, %

    		95%96%96%97%96%96%97%96%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    		3.2b4.1b4.9b6.2b7.0b4.2b

    Inventories

    		340.4m393.1m443.4m497.9m541.0m458.0m

    Current Assets

    		7.6b9.7b9.4b10.9b14.9b9.1b

    PP&E

    		593.4m642.6m814.1m929.8m1.1b1.4b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Cash

    		2.4b4.4b4.5b5.3b6.7b5.5b2.8b1.5b2.5b

    Inventories

    		313.3m360.0m372.0m386.7m414.3m509.0m533.0m537.0m536.0m555.0m510.0m

    Current Assets

    		7.6b6.9b8.1b9.7b9.9b8.4b9.2b11.6b13.1b14.8b7.9b6.9b7.8b

    PP&E

    		592.3m649.7m675.2m702.0m840.0m854.0m958.0m989.0m1.0b1.3b1.3b1.3b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    		1.4b2.0b1.6b2.0b2.9b4.0b

    Depreciation and Amortization

    		471.0m635.0m

    Inventories

    		(89.7m)(56.5m)(50.6m)(55.3m)(42.0m)82.0m

    Cash From Operating Activities

    		2.2b2.8b2.5b4.0b5.2b5.2b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Net Income

    		1.2b1.4b718.9m1.0b800.7m1.4b941.0m2.0b3.0b846.0m1.9b3.0b

    Depreciation and Amortization

    		71.8m28.1m29.2m58.5m32.0m240.0m355.0m126.0m296.0m465.0m

    Inventories

    		(62.6m)(7.0m)7.3m(25.6m)(45.2m)(10.0m)(32.0m)(37.0m)6.0m(14.0m)31.0m

    Cash From Operating Activities

    		1.7b856.5m974.9m1.9b853.0m2.5b3.6b(325.0m)904.0m2.8b
    show all
    Show all financial metrics

    Celgene Operating Metrics

    FY, 2016

    Active Clinical Studies

    		52
    Show all operating metrics

    Celgene Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Juno TherapeuticsJanuary 22, 2018$9 b
    Impact BiomedicinesJanuary 07, 2018
    Report incorrect company information

    Competitors

    Regeneron Pharmaceuticals
    Healthcare - Public
    Sanofi
    Healthcare - Public
    Gilead Sciences
    Healthcare - Public
    Amgen
    Healthcare - Public
    Shire
    Healthcare - Public
    Compare competitors

    Celgene Online and Social Media Presence

    Embed Graph
    Report incorrect company information

     Celgene Frequently Asked Questions

    • When was Celgene founded?

      Celgene was founded in 1986.

    • Who are Celgene key executives?

      Celgene's key executives are Mark J. Alles, Peter N. Kellogg and Nadim Ahmed.

    • What is Celgene revenue?

      Latest Celgene annual revenue is $15.3 b.

    • Who are Celgene competitors?

      Competitors of Celgene include Regeneron Pharmaceuticals, Sanofi and Gilead Sciences.

    • Where is Celgene headquarters?

      Celgene headquarters is located at 86 Morris Ave, Summit.

    • Where are Celgene offices?

      Celgene has offices in Summit, Boudry and Singapore.

    • How many offices does Celgene have?

      Celgene has 3 offices.

    Need Data?

    Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

    Learn more